ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection

被引:0
|
作者
Kepenekian, Vahan [1 ,2 ]
Peron, Julien [3 ,4 ]
You, Benoit [2 ]
Glehen, Olivier [1 ,2 ]
机构
[1] Hop Lyon Sud, Hosp Civils Lyon, Inst Cancerol HCL IC HCL, Dept Surg Oncol, Pierre Benite, France
[2] Univ Claude Bernard Lyon 1 UCBL1, CICLY, EA3738, Lyon, France
[3] Hosp Civils Lyon, Inst Cancerol, Serv Oncol Med, Lyon, France
[4] Univ Claude Bernard Lyon 1, Equipe Biostat Sante, Lab Biometrie & Biol Evolut, Villeurbanne, France
关键词
D O I
10.1245/s10434-021-10990-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2114 / 2115
页数:2
相关论文
共 14 条
  • [1] ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection
    Vahan Kepenekian
    Julien Péron
    Benoit You
    Olivier Glehen
    [J]. Annals of Surgical Oncology, 2022, 29 : 2114 - 2115
  • [2] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma
    Paul H. Sugarbaker
    [J]. Annals of Surgical Oncology, 2021, 28 : 7118 - 7119
  • [3] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma
    Sugarbaker, Paul H.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7118 - 7119
  • [4] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Chatterjee, Ambarish
    Kusamura, Shigeki
    Baratti, Dario
    Guaglio, Marcello
    Battaglia, Luigi
    Deraco, Marcello
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2511 - 2512
  • [5] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Chatterjee, Ambarish
    Kusamura, Shigeki
    Baratti, Dario
    Guaglio, Marcello
    Battaglia, Luigi
    Deraco, Marcello
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2511 - 2512
  • [6] ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols—Malignant Peritoneal Mesothelioma as a Model
    Vahan Kepenekian
    Olivia Sgarbura
    Frederic Marchal
    Laurent Villeneuve
    Shigeki Kusamura
    Marcello Deraco
    [J]. Annals of Surgical Oncology, 2023, 30 : 7858 - 7859
  • [7] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Ambarish Chatterjee
    Shigeki Kusamura
    Dario Baratti
    Marcello Guaglio
    Luigi Battaglia
    Marcello Deraco
    [J]. Annals of Surgical Oncology, 2024, 31 : 2511 - 2512
  • [8] ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model
    Kepenekian, Vahan
    Sgarbura, Olivia
    Marchal, Frederic
    Villeneuve, Laurent
    Kusamura, Shigeki
    Deraco, Marcello
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7858 - 7859
  • [9] Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study
    Kepenekian, Vahan
    Peron, Julien
    You, Benoit
    Bonnefoy, Isabelle
    Villeneuve, Laurent
    Alyami, Mohammad
    Bakrin, Naoual
    Rousset, Pascal
    Benzerdjeb, Nazim
    Glehen, Olivier
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 2104 - 2113
  • [10] Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study
    Vahan Kepenekian
    Julien Péron
    Benoit You
    Isabelle Bonnefoy
    Laurent Villeneuve
    Mohammad Alyami
    Naoual Bakrin
    Pascal Rousset
    Nazim Benzerdjeb
    Olivier Glehen
    [J]. Annals of Surgical Oncology, 2022, 29 : 2104 - 2113